Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/22/2025

Cephalexin Dosing and Management for Cellulitis

Adult Dosing Recommendations

  • The Infectious Diseases Society of America recommends cephalexin 500 mg four times daily (every 6 hours) as the standard oral regimen for typical non-purulent cellulitis in adults 1, 2
  • The usual duration of therapy is 5 days, but treatment should be extended if the infection has not improved within this time period, as suggested by the American College of Physicians 3, 4

Clinical Considerations

  • Cephalexin is the oral agent of choice for treating cellulitis caused by methicillin-susceptible strains of Staphylococcus aureus and streptococci, according to the Infectious Diseases Society of America 1, 5
  • For patients with non-purulent cellulitis without systemic signs of infection, oral antibiotics like cephalexin are appropriate for outpatient management, as recommended by the Infectious Diseases Society of America 2, 6
  • MRSA is an unusual cause of typical cellulitis - β-lactam monotherapy with cephalexin is recommended in the absence of abscess, ulcer, or purulent drainage, as suggested by the Infectious Diseases Society of America 6
  • Hospitalization should be considered if there is concern for deeper infection, poor adherence to therapy, immunocompromise, or if outpatient treatment is failing, according to the Infectious Diseases Society of America 7

Special Situations

  • For cellulitis associated with penetrating trauma, evidence of MRSA infection elsewhere, nasal colonization with MRSA, or injection drug use, consider adding coverage for MRSA, as recommended by the Infectious Diseases Society of America 5, 7
  • For penicillin-allergic patients (except those with immediate hypersensitivity reactions), cephalexin remains an option, according to the Infectious Diseases Society of America 1
  • Elevation of the affected area and treatment of predisposing factors (such as edema, tinea pedis, or venous insufficiency) are important adjunctive measures, as suggested by the Infectious Diseases Society of America 3, 6

Common Pitfalls to Avoid

  • Don't extend treatment unnecessarily - 5 days is as effective as 10 days for uncomplicated cellulitis if clinical improvement has occurred, as recommended by the American College of Physicians 4, 6
  • Don't overlook underlying conditions that may predispose to recurrent cellulitis (tinea pedis, venous insufficiency, lymphedema), as suggested by the Infectious Diseases Society of America 2, 6
  • Don't automatically add MRSA coverage for typical non-purulent cellulitis without risk factors for MRSA, according to the Infectious Diseases Society of America 5, 6
  • Don't forget to examine interdigital toe spaces in lower-extremity cellulitis, as treating fissuring or maceration may reduce recurrence, as recommended by the Infectious Diseases Society of America 3

Monitoring and Follow-up

  • For non-diabetic adult patients, systemic corticosteroids (e.g., prednisone 40 mg daily for 7 days) could be considered as they may attenuate the inflammatory response, as suggested by the Infectious Diseases Society of America 6, 8

REFERENCES